Gastroenterology
Volume 129, Issue 4 , Pages 1282-1293 , October 2005

Uncovered Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites: A Meta-Analysis

  • Gennaro D’Amico

      Affiliations

    • Unit of Gastroenterology, Ospedale V. Cervello, Palermo, Italy
    • Corresponding Author InformationAddress requests for reprints to: Gennaro D’Amico, MD, Unit of Gastroenterology, Ospedale V Cervello, Via Trabucco 180 90146, Palermo, Italy.; fax: (39) 091-6885111.
  • ,
  • Angelo Luca

      Affiliations

    • Istituto Mediterraneo per i Trapianti e Terapie ad alta Specializzazione (ISMETT), Palermo, Italy
  • ,
  • Alberto Morabito

      Affiliations

    • Cattedra di Statistica Medica, Dipartimento di Medicina e Chirurgia e Odontoiatria, Università di Milano, Milano, Italy
  • ,
  • Roberto Miraglia

      Affiliations

    • Istituto Mediterraneo per i Trapianti e Terapie ad alta Specializzazione (ISMETT), Palermo, Italy
  • ,
  • Mario D’amico

      Affiliations

    • Unit of Gastroenterology, Ospedale V. Cervello, Palermo, Italy

Received 18 January 2005 ,Accepted 30 March 2005.

References 

  1. Arroyo V , Colmenero J . Ascites and hepatorenal syndrome in cirrhosis (pathophysiological basis of therapy and current management) . J Hepatol . 2003;38:S69–S89
  2. Bosch J , Garcia-Pagan JC . Complications of cirrhosis. I. Portal hypertension . J Hepatol . 2000;32:141–146
  3. Gines P , Guevara M , Arroyo V , Rodes J . Hepatorenal syndrome . Lancet . 2003;362:1819–1827
  4. Moller S , Henriksen H . Review article (pathogenesis and pathophysiology of hepatorenal syndrome—is there a scope for prevention?) . Aliment Pharmacol Ther . 2004;20(Suppl 3):31–41
  5. Runyon BA . Refractory ascites . Semin Liver Dis . 1993;13:343–351
  6. Russo MW , Sood A , Jacobson IM , Brown SR . Transjugular intrahepatic portosystemic shunt for refractory ascites (an analysis of the literature on efficacy, morbidity and mortality) . Am J Gastroenterol . 2003;98:2521–2527
  7. Ochs A, Rossle M, Haag K, Hauenstein KH, Deibert P, Siegerstetter V, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites . N Engl J Med . 1995;332:1192–1197
  8. Quiroga J, Sangro B, Nuñez M, Bilbao I, Longo J, Garcia-Villarreal L, et al  Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites (effect on clinical, renal, humoral, and hemodynamic parameters) . Hepatology . 1995;21:986–994
  9. Forrest EH , Stanley AJ , Redhead DN , McGilchrist AJ , Hayes PC . Clinical response after transjugular intrahepatic portosystemic stent shunt insertion for refractory ascites in cirrhosis . Aliment Pharmacol Ther . 1996;10:801–806
  10. Lebrec D, Giuily N, Hadengue A, Vilgrain V, Moreau R, Poynard T, et al  Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial . J Hepatol . 1996;25:135–144
  11. Rossle M, Ochs A, Gulberg V, Siegerstetter V, Holl J, Deibert P, et al  A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites . N Engl J Med . 2000;342:1701–1707
  12. Gines P, Uriz J, Calahorra B, Garcia-Tsao G, Kamath PS, Del Arbol LR, et al  Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis . Gastroenterology . 2002;123:1839–1847
  13. Sanyal AJ, Genning C, Reddy KR, Wong F, Kowdley KV, Benner K, et al  The North American Study for the Treatment of Refractory Ascites . Gastroenterology . 2003;124:634–641
  14. Salerno F, Merli M, Riggio O, Cazzaniga M, Valeriano V, Pozzi M, et al. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites . Hepatology . 2004;40:629–635
  15. Pugh RN , Murray-Lyon IM , Dawson JL , Pietrni MC , Williams R . Transection of the esophagus for bleeding oesophageal varices . Br J Surg . 1973;60:646–649
  16. Saab S , Nieto JM , Ly D , Runyon BA . TIPS versus paracentesis for cirrhotic patients with refractory ascites . Cochrane Database Syst Rev . 2004;3:CD004889
  17. Conn HO , Liebertal MM . The hepatic coma syndromes and lactulose . Baltimore: Williams & Wilkins; 1979; 46–84
  18. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds JM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials (is blinding necessary?) . Control Clin Trials . 1996;17:1–12
  19. Moher D , Pham B , Jones A , Cook DJ , Jadad AR , Moher M , et al.   Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? . Lancet . 1998;352:609–613
  20. Juni P , Altman DG , Egger M . Assessing the quality of controlled clinical trials . BMJ . 2001;323:42–46
  21. Kjaergard LL , Villumsen J , Gluud C . Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses . Ann Intern Med . 2001;135:982–989
  22. Schulz KF , Grimes DA . Generation of allocation sequences in randomised trials (chance not choice) . Lancet . 2002;359:515–519
  23. Schulz KF , Grimes DA . Allocation concealment in randomised trials (defending against deciphering) . Lancet . 2002;359:614–618
  24. Schultz KF , Grimes AD . Blinding in randomised trials . Lancet . 2002;359:696–700
  25. Der Simonian R , Laird N . Meta-analysis in clinical trials . Control Clin Trials . 1986;7:177–188
  26. Laupacis A , Sackett DL , Roberts AS . An assessment of clinically useful measures of the consequences of treatment . N Engl J Med . 1988;318:1728–1733
  27. Altman DG . Confidence intervals for the number needed to treat . BMJ . 1998;317:1309–1312
  28. Petitti D . Approaches to heterogeneity in meta-analysis . Stat Med . 2001;20:3625–3633
  29. Thompson SG , Higgins JPT . How should meta-regression analyses be undertaken and interpreted . Stat Med . 2002;21:1559–1573
  30. Thompson SG , Sharp SG . Explaining heterogeneity in meta-analysis (a comparison of methods) . Stat Med . 1999;18:2693–2708
  31. Begg CB , Mazumadar M . Operating characteristics of a rank correlation test for publication bias . Biometrics . 1994;50:1088–1098
  32. Egger M , Smith DG , Schneider M , Minder C . Bias in meta-analysis detected by a simple, graphical test . BMJ . 1997;315:629–634
  33. Malinchoc M , Kamath P , Gordon FG , Peine CJ , Rank J , Ter Borg CGP . A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts . Hepatology . 2000;31:864–871
  34. Gerbes AL , Gulberg V . Benefit of TIPS for patients with refractory or recidivant ascites (serum bilirubin may make the difference) . Hepatology . 2005;41:217
  35. Rajan KD , Haskal ZJ , Clark TWI . Serum bilirubin and early mortality after transjugular intrahepatic portosystemic shunts (results of a multivariate analysis) . J Vasc Interv Radiol . 2002;13:156–161
  36. Brensing AK, Raab P, Textor J, Gorich J, Schiedermaier P, Strunk H, et al  Prospective evaluation of a clinical score for 60-day mortality after transjugular intrahepatic portosystemic stent-shunt (Bonn TIPS early mortality analysis) . Eur J Gastroenterol Hepatol . 2002;14:723–731
  37. Rossle M . Discussion on the North American study for the treatment of refractory ascites . Gastroenterology . 2004;126:1214–1215
  38. Garcia-Tsao G . Treatment of refractory ascites (TIPS or TAPS) . Hepatology . 2001;33:477–479
  39. Burroughs AK , Vangeli M . Transjugular intrahepatic portosystemic shunt versus endoscopic therapy. Randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis . Scand J Gastroenterol . 2002;37:249–252
  40. Sanyal AJ , Freedman AM , Shiffman ML , Purdum PP , Luketic VA , Cheatham AK . Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt (results of a prospective controlled study) . Hepatology . 1994;20:46–55
  41. Somberg KA , Riegler JL , Doherty M , et al.   Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts (incidence and risk factors) . Am J Gastroenterol . 1995;4:549–555
  42. Cabrera J , Maynar M , Granados R , et al.   Tansjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage . Gastroenterology . 1996;110:832–839
  43. Rössle M , Deibert P , Haag K , et al.   Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding . Lancet . 1997;249:1043–1049
  44. Sauer P , Theilmann L , Stremmel W , Benz C , Richter GM , Stiehl A . Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for rebleeding . Gastroenterology . 1997;113:1623–1631
  45. Nolte W, Wiltfang J, Schindler C, Munke H, Unterberg K, Zumhasch U, et al  Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis (clinical, laboratory, psychometric and electroencephalographic investigations) . Hepatology . 1998;28:1215–1225
  46. Hassoun Z, Deschenes M, Lafortune M, Dufresne MP, Perrault P, Lepanto L, et al  Relationship between pre-TIPS liver perfusion by the portal vein and the incidence of post-TIPS chronic hepatic encephalopathy . Am J Gastroenterol . 2001;96:1205–1209
  47. Bureau C, Garcia-Pagan JC, Otal P, Pomier-Layrargues G, Chabbert V, Cortez C, et al  Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS (results of a randomized study) . Gastroenterology . 2004;126:469–475
  48. Ginès P, Arroyo V, Vargas B, Planas R, Casafont F, Panés J, et al  Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites . N Engl J Med . 1991;325:829–835
  49. Arroyo V, Ginès P, Gerbes AL, Dudley JF, Gentilini P, Laffi G, et al  Definitions and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis . Hepatology . 1996;23:164–176
  50. Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seef L, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy . Gastroenterology . 1977;72:573–583

PII: S0016-5085(05)01431-9

doi: 10.1053/j.gastro.2005.07.031

Gastroenterology
Volume 129, Issue 4 , Pages 1282-1293 , October 2005